Smith & Nephew is reconstruction and sports medicine and one of the world's leading orthopedic suppliers.
Smith & Nephew is a global medical technology company with revenues of approximately $5.8 billion in 2025 across three primary divisions: Orthopaedics (hip and knee reconstruction), Sports Medicine & ENT (arthroscopic surgery and soft tissue repair), and Advanced Wound Management. The CORI robotic system for knee arthroplasty represents Smith & Nephew's primary competitive response to Mako. The company's sports medicine portfolio — including the FAST-FIX meniscal repair system and HEALICOIL anchor systems — competes directly with Arthrex, the segment's most focused specialist.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Acquisitions and divestitures
• Marketing tactics
• Financial results
• Strengths and weaknesses
• Strategic directions
Table of Contents
1. Executive Summary
2. Company Overview and Business Model
3. Strategic Directions
4. Financial Results
5. SWOT Analysis
6. Technological Know-How and Key Products
7. Acquisitions and Divestitures
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Smith & Nephew — Key Financial Metrics 2023-2025
Table 2. Smith & Nephew — Revenue by Segment 2023-2025
Table 3. Smith & Nephew — Revenue by Geography 2023-2025
Table 4. Smith & Nephew — SWOT Analysis
Table 5. Smith & Nephew — Key Products and Platforms 2025
Table 6. Smith & Nephew — M&A Activity 2020-2025
Table 7. Smith & Nephew — Key Management 2025
Table 8. Smith & Nephew — Strategic Priorities 2025-2030
